Answers are grounded in this paper and cite their sources.
-LLO have been developed to combat cancer cells. When used in tandem with conventional treatments, GEB substantially improve the efficacy of anticancer therapy outcomes. In addition, public acceptance, optimal timing (s), duration (s), dose (s), and strains identification, interactions with other strains and the host cells, efficacy, safety and quality, and potential risks and ethical dilemmas include major challenges.
No takes yet. Share an insight, caveat, or question.
Zahedifard et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: